Covered recipient · General Payments record
ALI IBRAHIM NASRALLAH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$316.39
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $231.75 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BIOTISSUE HOLDINGS INC. | $58.48 | 2 |
| Lilly USA, LLC | $43.67 | 2 |
| Exact Sciences Corporation | $40.63 | 2 |
| PFIZER INC. | $31.14 | 2 |
| SHIELD THERAPEUTICS INC | $20.73 | 1 |
| Amgen Inc. | $19.85 | 1 |
| Novo Nordisk AS | $17.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $19.85 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111660143 | CMS |
| BIOTISSUE HOLDINGS INC. | $30.49 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148780005 | CMS |
| BIOTISSUE HOLDINGS INC. | $27.99 | 05/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148773308 | CMS |
| Exact Sciences Corporation | $22.00 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114466733 | CMS |
| Exact Sciences Corporation | $18.63 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114466738 | CMS |
| Lilly USA, LLC | $22.86 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136019080 | CMS |
| Lilly USA, LLC | $20.81 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136022949 | CMS |
| Novo Nordisk Inc | $17.25 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097182893 | CMS |
| PFIZER INC. | $16.43 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131765432 | CMS |
| PFIZER INC. | $14.71 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132084244 | CMS |
| SHIELD THERAPEUTICS INC | $20.73 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150131291 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.